Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series) - Image 1

£60.89

CRC Press Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

Name: Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
Brand: CRC Press
Price: 61.18 GBP
Availability: InStock

Allied Health Professions

Price History & Forecast

Last 41 days • 41 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 41 days • 1 price levels

Days at Price

Price Analysis

Most common price: £61 (41 days, 100.0%)

Price range: £61 - £61

Price levels: 1 different prices over 41 days

Description

Theory of Drug Development presents a formal quantitative framework for understanding drug development that goes beyond simply describing the properties of the statistics in individual studies. It examines the drug development process from the perspectives of drug companies and regulatory agencies. By quantifying various ideas underlying drug development, the book shows how to systematically address problems, such as: Sizing a phase 2 trial and choosing the range of p-values that will trigger a follow-up phase 3 trial Deciding whether a drug should receive marketing approval based on its phase 2/3 development program and recent experience with other drugs in the same clinical area Determining the impact of adaptive designs on the quality of drugs that receive marketing approval Designing a phase 3 pivotal study that permits the data-driven adjustment of the treatment effect estimate Knowing when enough information has been gathered to show that a drug improves the survival time for the whole patient population Drawing on his extensive work as a statistician in the pharmaceutical industry, the author focuses on the efficient development of drugs and the quantification of evidence in drug development. He provides a rationale for underpowered phase 2 trials based on the notion of efficiency, which leads to the identification of an admissible family of phase 2 designs. He also develops a framework for evaluating the strength of evidence generated by clinical trials. This approach is based on the ratio of power to type 1 error and transcends typical Bayesian and frequentist statistical analyses.

Product Specifications

Brand: CRC Press
Format: paperback
ASIN: 1138374687
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions
Domain: Amazon UK
Release Date: 30 August 2019
Listed Since: 25 November 2018

Barcode

No barcode data available

CRC Press Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

Statistical Methods in Drug Combination Studies: 69 (Chapman & Hall/CRC Biostatistics Series)

Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Quantitative Decisions in Drug Development (Springer Series in Pharmaceutical Statistics)

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

New Drug Development: An Introduction to Clinical Trials: Second Edition

New Drug Development: An Introduction to Clinical Trials: Second Edition

Statistical Design, Monitoring, and Analysis of Clinical Trials: Principles and Methods (Chapman & Hall/CRC Biostatistics Series)

Quantitative Methods for Traditional Chinese Medicine Development (Chapman & Hall/Crc Biostatistics)

Phase II Clinical Development of New Drugs (ICSA Book Series in Statistics)

Handbook of Adaptive Designs in Pharmaceutical and Clinical Development

Quantitative Methods for Traditional Chinese Medicine Development: 83 (Chapman & Hall/CRC Biostatistics)

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

Adaptive Design Theory and Implementation Using SAS and R (Chapman & Hall/CRC Biostatistics Series)

Adaptive Design Theory and Implementation Using SAS and R (Chapman & Hall/CRC Biostatistics Series)

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

Clinical Trial Biostatistics and Biopharmaceutical Applications

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Design and Analysis of Clinical Trials with Time-to-Event Endpoints (Chapman & Hall/CRC Biostatistics Series)

Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)